A citation-based method for searching scientific literature

David H Chi, Karl Kandler. Neurosci Lett 2012
Times Cited: 5







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Mechanisms of sound localization in mammals.
Benedikt Grothe, Michael Pecka, David McAlpine. Physiol Rev 2010
449
60




Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse.
Christopher Kushmerick, Gareth D Price, Holger Taschenberger, Nagore Puente, Robert Renden, Jacques I Wadiche, Robert M Duvoisin, Pedro Grandes, Henrique von Gersdorff. J Neurosci 2004
84
40

The origin of spontaneous activity in the developing auditory system.
Nicolas X Tritsch, Eunyoung Yi, Jonathan E Gale, Elisabeth Glowatzki, Dwight E Bergles. Nature 2007
342
40

Endocannabinoid signaling and synaptic function.
Pablo E Castillo, Thomas J Younts, Andrés E Chávez, Yuki Hashimotodani. Neuron 2012
510
40


Anatomy of the cochlear nuclear complex of guinea pig.
C M Hackney, K K Osen, J Kolston. Anat Embryol (Berl) 1990
158
40

The neuronal architecture of the cochlear nucleus of the cat.
J R Brawer, D K Morest, E C Kane. J Comp Neurol 1974
446
40

Progressive brain changes in children and adolescents with first-episode psychosis.
Celso Arango, Marta Rapado-Castro, Santiago Reig, Josefina Castro-Fornieles, Ana González-Pinto, Soraya Otero, Inmaculada Baeza, Carmen Moreno, Montserrat Graell, Joost Janssen,[...]. Arch Gen Psychiatry 2012
99
20


Molecular model of cannabis sensitivity in developing neuronal circuits.
Erik Keimpema, Ken Mackie, Tibor Harkany. Trends Pharmacol Sci 2011
55
20

Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users.
Marta Di Forti, Conrad Iyegbe, Hannah Sallis, Anna Kolliakou, M Aurora Falcone, Alessandra Paparelli, Miriam Sirianni, Caterina La Cascia, Simona A Stilo, Tiago Reis Marques,[...]. Biol Psychiatry 2012
146
20

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Theresa H M Moore, Stanley Zammit, Anne Lingford-Hughes, Thomas R E Barnes, Peter B Jones, Margaret Burke, Glyn Lewis. Lancet 2007
20

Prediction of psychosis by mismatch negativity.
Mitja Bodatsch, Stephan Ruhrmann, Michael Wagner, Ralf Müller, Frauke Schultze-Lutter, Ingo Frommann, Jürgen Brinkmeyer, Wolfgang Gaebel, Wolfgang Maier, Joachim Klosterkötter,[...]. Biol Psychiatry 2011
191
20



Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.
Patrik Roser, Ida S Haussleiter, Hee-Jeong Chong, Christoph Maier, Wolfram Kawohl, Christine Norra, Georg Juckel. Psychopharmacology (Berl) 2011
19
20

Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis.
James M Stone, Oliver D Howes, Alice Egerton, Joseph Kambeitz, Paul Allen, David J Lythgoe, Ruth L O'Gorman, Mary A McLean, Gareth J Barker, Philip McGuire. Biol Psychiatry 2010
88
20

Auditory mismatch negativity deficits in long-term heavy cannabis users.
Patrik Roser, Beate Della, Christine Norra, Idun Uhl, Martin Brüne, Georg Juckel. Eur Arch Psychiatry Clin Neurosci 2010
20
20



Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study.
Stanley Zammit, Peter Allebeck, Sven Andreasson, Ingvar Lundberg, Glyn Lewis. BMJ 2002
483
20

Cannabis-induced psychosis-like experiences are associated with high schizotypy.
E J Barkus, J Stirling, R S Hopkins, S Lewis. Psychopathology 2006
110
20

Duration and frequency mismatch negativity in schizophrenia.
P T Michie, T W Budd, J Todd, D Rock, H Wichmann, J Box, A V Jablensky. Clin Neurophysiol 2000
124
20


The mismatch negativity: an index of cognitive decline in neuropsychiatric and neurological diseases and in ageing.
Risto Näätänen, Teija Kujala, Kairi Kreegipuu, Synnöve Carlson, Carles Escera, Torsten Baldeweg, Curtis Ponton. Brain 2011
141
20

The mismatch negativity (MMN)--a unique window to disturbed central auditory processing in ageing and different clinical conditions.
R Näätänen, T Kujala, C Escera, T Baldeweg, K Kreegipuu, S Carlson, C Ponton. Clin Neurophysiol 2012
233
20

Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines.
Rebecca Kuepper, Paul D Morrison, Jim van Os, Robin M Murray, Gunter Kenis, Cécile Henquet. Schizophr Res 2010
74
20

Review of the validity and significance of cannabis withdrawal syndrome.
Alan J Budney, John R Hughes, Brent A Moore, Ryan Vandrey. Am J Psychiatry 2004
296
20


Event-related potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400.
Connie C Duncan, Robert J Barry, John F Connolly, Catherine Fischer, Patricia T Michie, Risto Näätänen, John Polich, Ivar Reinvang, Cyma Van Petten. Clin Neurophysiol 2009
600
20

Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers.
J Hirvonen, R S Goodwin, C-T Li, G E Terry, S S Zoghbi, C Morse, V W Pike, N D Volkow, M A Huestis, R B Innis. Mol Psychiatry 2012
328
20

Deviant matters: duration, frequency, and intensity deviants reveal different patterns of mismatch negativity reduction in early and late schizophrenia.
Juanita Todd, Patricia T Michie, Ulrich Schall, Frini Karayanidis, Hirooki Yabe, Risto Näätänen. Biol Psychiatry 2008
158
20

Mismatch negativity (MMN) reduction in schizophrenia-impaired prediction--error generation, estimation or salience?
Juanita Todd, Patricia T Michie, Ulrich Schall, Philip B Ward, Stanley V Catts. Int J Psychophysiol 2012
72
20

Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.
Johannes Rentzsch, Elise Buntebart, Ada Stadelmeier, Jürgen Gallinat, Maria C Jockers-Scherübl. Schizophr Res 2011
25
20

Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use.
Stanley Zammit, Gillian Spurlock, Hywel Williams, Nadine Norton, Nigel Williams, Michael C O'Donovan, Michael J Owen. Br J Psychiatry 2007
118
20

Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study.
Rebecca Kuepper, Jim van Os, Roselind Lieb, Hans-Ulrich Wittchen, Michael Höfler, Cécile Henquet. BMJ 2011
176
20

Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia.
Daniel S G Umbricht, John A Bates, Jeffrey A Lieberman, John M Kane, Daniel C Javitt. Biol Psychiatry 2006
149
20

Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum.
Matthijs G Bossong, Bart N M van Berckel, Ronald Boellaard, Lineke Zuurman, Robert C Schuit, Albert D Windhorst, Joop M A van Gerven, Nick F Ramsey, Adriaan A Lammertsma, René S Kahn. Neuropsychopharmacology 2009
261
20

Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?
Nadia Solowij, Patricia T Michie. J Psychiatry Neurosci 2007
147
20

Differential relationships of mismatch negativity and visual p1 deficits to premorbid characteristics and functional outcome in schizophrenia.
Tamara Friedman, Pejman Sehatpour, Elisa Dias, Megan Perrin, Daniel C Javitt. Biol Psychiatry 2012
58
20

Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
Alexander F Hoffman, Murat Oz, Ruiqin Yang, Aron H Lichtman, Carl R Lupica. Learn Mem 2007
99
20


Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study.
D Sun, G W Stuart, M Jenkinson, S J Wood, P D McGorry, D Velakoulis, T G M van Erp, P M Thompson, A W Toga, D J Smith,[...]. Mol Psychiatry 2009
98
20

Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice.
Richard S Ehrlichman, Christina R Maxwell, Sonalee Majumdar, Steven J Siegel. J Cogn Neurosci 2008
111
20


Evidence that three dimensions of psychosis have a distribution in the general population.
N C Stefanis, M Hanssen, N K Smirnis, D A Avramopoulos, I K Evdokimidis, C N Stefanis, H Verdoux, J Van Os. Psychol Med 2002
513
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.